Does ENZALUTAMIDE Cause Retching? 103 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Retching have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
103
Reports of Retching with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
9
Deaths
21
Hospitalizations
How Dangerous Is Retching From ENZALUTAMIDE?
Of the 103 reports, 9 (8.7%) resulted in death, 21 (20.4%) required hospitalization.
Is Retching Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Retching?
TREPROSTINIL (485)
SODIUM OXYBATE (376)
ADALIMUMAB (313)
SEMAGLUTIDE (284)
TROFINETIDE (250)
NIRAPARIB (226)
MAGNESIUM\POTASSIUM\SODIUM (195)
ALBUTEROL (192)
DUPILUMAB (187)
IBUPROFEN (184)
Which ENZALUTAMIDE Alternatives Have Lower Retching Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE